Tag: Depression

Moderate and extreme anxiety/depression linked to HRQoL losses, regardless of pain or discomfort

CR plus transcranial direct current stimulation slows cognitive decline in older adults with remitted MDD with or without MCI

Significant reduction seen in secondary outcome of long-term depression but not in medium-term depression

Better remission and response seen with bright light therapy before four weeks and after four weeks

Highest rates seen during COVID-19 pandemic versus before pandemic and in females, those aged 14 to 17 and 18 to 22 years

Small, but significant effects seen at six months and sustained at 12 months

Additionally, a higher prevalence of lifetime suicide plan and attempts was observed

Findings seen for attention-deficit/hyperactivity disorder or depressive disorder

Estimated percentage eligible ranges from 24 to 62 percent depending on eligibility criteria used